CUSIP: 744375205
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,625,592
-
Share change
-
-23,047
-
Total reported value
-
$15,885,757
-
Price per share
-
$6.05
-
Number of holders
-
32
-
Value change
-
-$288,113
-
Number of buys
-
10
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2020
-
Previous quarter:
Q4 2019
Recent filing periods for CUSIP 744375205:
Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q1 2020
As of 31 Mar 2020,
PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,625,592 shares.
The largest 10 holders included
KENNEDY CAPITAL MANAGEMENT, INC., RENAISSANCE TECHNOLOGIES LLC, CRAWFORD INVESTMENT COUNSEL INC, VANGUARD GROUP INC, Tieton Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., Ancora Advisors, LLC, RBF Capital, LLC, and BLAIR WILLIAM & CO/IL.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.